Antacid versus cimetidine in preventing acute gastrointestinal bleeding. A randomized trial in 75 critically ill patients

The New England Journal of Medicine
H J PriebeW Silen

Abstract

Over a 15-month period, 75 critically ill patients at risk of acute gastrointestinal bleeding were randomized into two groups: one group (38 patients) received the H2-blocker cimetidine intravenously at an initial dosage of 300 mg every six hours, and the other group (37 patients) received antacid (Mylanta II) through a nasogastric tube at an intial dosage of 30 ml every hour. Gastric pH was measured hourly and titrated above 3.5. Upper-gastrointestinal-tract bleeding occurred in seven of 38 cimetidine-treated patients but in none of 37 antacid-treated patients (P less than 0.01). When antacid titration was added to the cimetidine regimen in four of seven patients with bleeding, all four stopped bleeding. Renal failure, sepsis, peritonitis, hypotension, respiratory failure, jaundice, multiple trauma, and major operative procedures were associated with an increased incidence of bleeding. Cimetidine does not adequately protect seriously ill patients from acute upper-gastrointestinal-tract bleeding. Antacid is better for this purpose.

References

Jan 1, 1977·American Journal of Surgery·P SmithW Silen
Oct 1, 1976·Annals of Surgery·S J Simonian, L E Curtis
Apr 1, 1979·Archives of Surgery·L F MartinM H Max
Apr 1, 1979·Archives of Surgery·V Herrmann, D L Kaminski
Aug 16, 1979·The New England Journal of Medicine·E Kivilaakso, W Silen
Aug 1, 1976·The Journal of Trauma·J C McAlhanyB A Pruitt
Apr 1, 1971·Archives of Surgery·C E LucasA J Walt

❮ Previous
Next ❯

Citations

Feb 1, 1990·Journal of Clinical Pharmacology·S SaimaT Ishizaki
Jun 1, 1990·Journal of Clinical Pharmacology·W J SandbornR M Strong
Jan 1, 1989·European Journal of Clinical Pharmacology·J A MartynD C Hoaglin
Feb 1, 1991·Digestive Diseases and Sciences·U K Murthy, W G Linscheer
Dec 1, 1992·Digestive Diseases and Sciences·J G MooreS Maggio
Oct 1, 1988·Digestive Diseases and Sciences·A M Granda
May 1, 1990·Digestive Diseases and Sciences·L C BaakC B Lamers
Jun 1, 1987·World Journal of Surgery·B E StabileE Passaro
Mar 1, 1981·World Journal of Surgery·F G MoodyK R Larsen
Mar 1, 1981·World Journal of Surgery·W SilenJ N Simson
Mar 1, 1981·World Journal of Surgery·B A Pruitt, C W Goodwin
Mar 1, 1981·World Journal of Surgery·H J Priebe, J J Skillman
Mar 1, 1981·World Journal of Surgery·L Y Cheung
Jan 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D E Craven, F D Daschner
May 1, 1986·Canadian Anaesthetists' Society Journal·S R Reid, C D Bayliff
Aug 30, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·H A van EssenW H Bakker
Feb 6, 1990·European Journal of Pharmacology·S J KonturekC Nauert
Sep 1, 1982·Injury·W E El MasriJ R Silver
Jul 1, 1993·International Journal of Antimicrobial Agents·G BleichnerJ P Sollet
May 24, 1980·Lancet·P StenbergI M Nilsson
May 24, 1980·Lancet·H Holden
May 24, 1980·Lancet·P Dawes, S T Atherton
Jan 31, 1981·Lancet·D P MikhailidisP Dandona
Jun 1, 1997·Burns : Journal of the International Society for Burn Injuries·T RaffB Hartmann
Jul 10, 1980·The New England Journal of Medicine·D S Bloom
Mar 19, 1981·The New England Journal of Medicine·J FeelyA J Wood
Apr 2, 1981·The New England Journal of Medicine·A HauserT Robbins
May 21, 1981·The New England Journal of Medicine·R R Schade, R M Donaldson
Jun 25, 1981·The New England Journal of Medicine·G SudlowP Goldman
Mar 17, 1983·The New England Journal of Medicine·C E Welch, R A Malt
Dec 1, 1983·The New England Journal of Medicine·J B ZeldisK J Isselbacher
Jan 14, 1984·Minerva medica·L Barbara, G Dobrilla
Dec 20, 1990·The New England Journal of Medicine·M Feldman, M E Burton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.